Cancer Diagnosis and Treatment Set for Major Upgrade in Tamil Nadu

Cancer diagnosis and treatment set for major upgrade in Tamil Nadu

Tamil Nadu government allocates Rs. 110 crores to enhance cancer diagnosis and treatment services in 17 institutions.

JCI Disruption of the KLHL37–N-Myc complex restores N-Myc degradation and arrests neuroblastoma growth in mouse models

The N-Myc gene MYCN amplification accounts for the most common genetic aberration in neuroblastoma and strongly predicts the aggressive progression and poor clinical prognosis. However, clinically effective therapies that directly target N-Myc activity are limited. N-Myc is a transcription factor, and its stability is tightly controlled by ubiquitination-dependent proteasomal degradation. Here, we discovered that Kelch-like protein 37 (KLHL37) p…

India Marks Breakthrough in Cancer Care: Tata Memorial Pioneers High-Dose MIBG Therapy - PUNE PULSE

In a landmark development for cancer treatment in India, Mumbai’s Tata Memorial Centre has become the first hospital in the country to successfully deliver high-dose MIBG therapy — a targeted nuclear medicine technique crucial in treating neuroblastoma, a rare and aggressive childhood cancer. The breakthrough treatment was administered on May 5, 2025, at Tata Memorial’s